A vs B [Design Issues]

posted by mittyri – Russia, 2020-02-03 22:05 (1599 d 21:25 ago) – Posting: # 21136
Views: 3,208

Hi John,

citing our Hero:

If one is really interested in λz and has no SD-phase in the study, sampling should continue until concentrations from previous doses are washed out – I would expect any estimate within the MD-profile to be biased towards faster elimination.

❝ I have seen both designs but I (and my former bosses) prefer method A. The only drawback I see from A is it takes longer time.


why does A take longer time?


Edit: Changed to internal link; see also this post #7[Helmut]

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,664 registered users;
32 visitors (0 registered, 32 guests [including 7 identified bots]).
Forum time: 20:31 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5